The Ministry of Health announced this Thursday that the Conditional Sanitary Registry of the new coronavirus vaccine Janssen, better known as Johnson & Johnson.
As they specified, the authorization was made by the General Directorate of Medicines, Supplies and Drugs (Digemid).
They also indicated that the registration already allows the use in our country of the compound registered by pharmacists of the groups Johnson & Johnson from the United States and Janssen from Belgium.
One of the most remarkable features of the Johnson & Johnson vaccine is that it is a single dose.
Fourth vaccination with registration
From the Minsa they specified that the Conditional Sanitary Registry of Digems it lasts for one year and can be renewed.
This registry was created to allow experimental vaccines against COVID-19 can be used and imported into our country.
Johnson & Johnson’s is the fourth vaccine against COVID-19 authorized for use in Peru, after Pfizer, Sinopharm and AstraZeneca.
Newsletter All about the coronavirus
COVID-19 has put everyone on alert. Subscribe to our newsletter All about the coronavirus, where you will find the most relevant daily data in the country and the world on the progress of the virus and the fight against its spread.
NUESTROS PODCASTS:
– ‘Vital Space’: How long does immunity last after COVID-19 infection?
– .
